These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 20466970)

  • 1. The tobacco use management system: analyzing tobacco control from a systems perspective.
    Borland R; Young D; Coghill K; Zhang JY
    Am J Public Health; 2010 Jul; 100(7):1229-36. PubMed ID: 20466970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimising the harm from nicotine use: finding the right regulatory framework.
    Borland R
    Tob Control; 2013 May; 22 Suppl 1(Suppl 1):i6-9. PubMed ID: 23591515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The global tobacco disease pandemic: nature, causes, and cures.
    Warner KE; Mackay J
    Glob Public Health; 2006; 1(1):65-86. PubMed ID: 19153895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tobacco control in France: what's new ?].
    Wirth N; Béguinot E; Martinet Y
    Rev Prat; 2019 Jun; 69(6):653-657. PubMed ID: 31626428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A global approach to tobacco policy.
    Gray N
    Lung Cancer; 2003 Feb; 39(2):113-7. PubMed ID: 12581561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The future of the nicotine-addiction market.
    Gray N; Boyle P
    Lancet; 2003 Sep; 362(9387):845-6. PubMed ID: 13678968
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of tobacco control policies in reducing smoking and deaths caused by smoking in an Eastern European nation: results from the Albania SimSmoke simulation model.
    Levy DT; Ross H; Zaloshnja E; Shuperka R; Rusta M
    Cent Eur J Public Health; 2008 Dec; 16(4):189-98. PubMed ID: 19256288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tobacco Control Plan is needed to fight the power of big tobacco.
    Watson MC; Lloyd J
    BMJ; 2017 Jan; 356():j351. PubMed ID: 28115315
    [No Abstract]   [Full Text] [Related]  

  • 9. The missing link in tobacco control.
    Ebbert JO; Hays JT
    CMAJ; 2008 Jul; 179(2):123-4. PubMed ID: 18625975
    [No Abstract]   [Full Text] [Related]  

  • 10. Government action to reduce smoking.
    Sandford A
    Respirology; 2003 Mar; 8(1):7-16. PubMed ID: 12856736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotine reduction revisited: science and future directions.
    Hatsukami DK; Perkins KA; Lesage MG; Ashley DL; Henningfield JE; Benowitz NL; Backinger CL; Zeller M
    Tob Control; 2010 Oct; 19(5):e1-10. PubMed ID: 20876072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Institutions and the implementation of tobacco control in Brazil.
    Lencucha R; Drope J; Bialous SA; Richter AP; Silva VLDCE
    Cad Saude Publica; 2017 Oct; 33Suppl 3(Suppl 3):e00168315. PubMed ID: 29069213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analyzing big tobacco's global youth marketing strategies and factors influencing smoking initiation by Nigeria youths using the theory of triadic influence.
    Isip U; Calvert J
    BMC Public Health; 2020 Mar; 20(1):377. PubMed ID: 32197659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of Canadian legislators' support for tobacco control policies.
    Cohen JE; de Guia NA; Ashley MJ; Ferrence R; Northrup DA; Studlar DT
    Soc Sci Med; 2002 Sep; 55(6):1069-76. PubMed ID: 12220090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The U.S. Food and Drug Administration's New Plan to Combat Tobacco's Staggering Public Health Toll.
    Abram A; Zeller M
    Ann Am Thorac Soc; 2019 Jan; 16(1):40-43. PubMed ID: 30339472
    [No Abstract]   [Full Text] [Related]  

  • 16. Tobacco harm reduction: how rational public policy could transform a pandemic.
    Sweanor D; Alcabes P; Drucker E
    Int J Drug Policy; 2007 Mar; 18(2):70-4. PubMed ID: 17689347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Learning from Philip Morris: Japan Tobacco's strategies regarding evidence of tobacco health harms as revealed in internal documents from the American tobacco industry.
    Iida K; Proctor RN
    Lancet; 2004 May; 363(9423):1820-4. PubMed ID: 15172783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing tobacco addiction through tobacco product regulation.
    Henningfield JE; Benowitz NL; Connolly GN; Davis RM; Gray N; Myers ML; Zeller M
    Tob Control; 2004 Jun; 13(2):132-5. PubMed ID: 15175528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Markers of the denormalisation of smoking and the tobacco industry.
    Chapman S; Freeman B
    Tob Control; 2008 Feb; 17(1):25-31. PubMed ID: 18218803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The "success" of Philip Morris' campaign on environmental tobacco smoke in The Netherlands.
    Nellen MA; De Blij BA
    Tob Control; 1999; 8(2):221-2. PubMed ID: 10478411
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.